Evidence map›Paper›PMID 33320391›Full record

ArticleProteins2021

Lysine-arginine advanced glycation end-product cross-links and the effect on collagen structure: A molecular dynamics study.

Anthony Nash, Sang Young Noh, Helen L Birch, Nora H de Leeuw

Open access · hybridAbstract read
In one paragraph

Article in Proteins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. The influence of AGEs and enzymatic cross-links on the mechanical properties of collagen fibrils.Journal of the mechanical behavior of biomedical materials · 2023
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Anthony NashNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.ORCID 0000-0001-8212-0302
Sang Young NohDepartment of Chemistry, University of Warwick, Coventry, UK.
Helen L BirchDepartment of Orthopaedics and Musculoskeletal Science, Stanmore Campus, University College London, London, UK.
Nora H de LeeuwSchool of Chemistry, University of Leeds, Leeds, UK.
Stanmore College · GBUniversity of Leeds · GBUniversity of Oxford · GBUniversity of Warwick · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K007785Department of Health BRC-1215-20005
6 · The paper itself

Abstract

The accumulation of advanced glycation end-products is a fundamental process that is central to age-related decline in musculoskeletal tissues and locomotor system function and other collagen-rich tissues. However, although computational studies of advanced glycation end-product cross-links could be immensely valuable, this area remains largely unexplored given the limited availability of structural parameters for the derivation of force fields for Molecular Dynamics simulations. In this article, we present the bonded force constants, atomic partial charges and geometry of the arginine-lysine cross-links DOGDIC, GODIC, and MODIC. We have performed in vacuo Molecular Dynamics simulations to validate their implementation against quantum mechanical frequency calculations. A DOGDIC advanced glycation end-product cross-link was then inserted into a model collagen fibril to explore structural changes of collagen and dynamics in interstitial water. Unlike our previous studies of glucosepane, our findings suggest that intra-collagen DOGDIC cross-links furthers intra-collagen peptide hydrogen-bonding and does not promote the diffusion of water through the collagen triple helices.

Indexed as

ArginineBinding SitesCollagenCross-Linking ReagentsDipeptidesGlycation End Products, AdvancedHydrogen BondingImidazolesLysineMolecular Dynamics SimulationProtein BindingProtein ConformationStatic ElectricityWater2-ammonio-6-((2-((4-ammonio-5-oxido-5-oxopentyl)amino)-4,5-dihydro-1H-imidazol-5-ylidene)amino)hexanoate2-ammonio-6-((2-((4-ammonio-5-oxido-5--oxopentyl)amino)-4-methyl-4,5-dihydro-1H-imidazol-5-ylidene)amino)hexanoateArgininearginyllysineCollagenCross-Linking ReagentsDipeptidesGlycation End Products, AdvancedImidazolesLysineN(6)-(2-((4-ammonio-5-oxido-5-oxopentyl)amino)-5-(2,3,4-trihydroxybutyl)3,5-dihydro-4H-imidazol-4-ylidene)lysinateWateradvanced glycation end-productsagingcollagencross-linkingDOGDICglucosepanematrix biology

Identifiers

PMID33320391
PMCPMC8048459
OpenAlexW3110763988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.